Evidence map›Paper›PMID 40573907›Full record

ArticleVaccines2025

Comprehensive Assessment of Reactogenicity and Safety of the Live-Attenuated Chikungunya Vaccine (IXCHIQ

Gabriele Maurer, Vera Buerger, Julian Larcher-Senn, Florian Erlsbacher, Stéphanie Meyer, Susanne Eder-Lingelbach, Juan Carlos Jaramillo

Abstract read
In one paragraph

Article in Vaccines, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Gabriele MaurerValneva Austria GmbH, 1030 Vienna, Austria.
Vera BuergerValneva Austria GmbH, 1030 Vienna, Austria.ORCID 0009-0008-9884-1006
Julian Larcher-SennAssign Data Management and Statistics GmbH, 6020 Innsbruck, Austria.ORCID 0000-0003-3169-1900
Florian ErlsbacherAssign Data Management and Statistics GmbH, 6020 Innsbruck, Austria.
Stéphanie MeyerValneva SE, 69002 Lyon, France.
Susanne Eder-LingelbachValneva Austria GmbH, 1030 Vienna, Austria.
Juan Carlos JaramilloValneva Austria GmbH, 1030 Vienna, Austria.

Funding

Valneva Austria GmbH, Coalition for Epidemic Preparedness Innovation (CEPI) and EU Horizon 2020 Not applicable
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

chikungunyalive-attenuatedpooled analysissafetysubgroupvaccine

Identifiers

PMID40573907
PMCPMC12197765

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.